Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation
Capizzi, R.L.; Yang, J.L.; Rathmell, J.P.; White, J.C.; Cheng, E.; Cheng, Y.C.; Kute, T.
Seminars in Oncology 12(2 Suppl 3: 65-74
1985
ISSN/ISBN: 0093-7754 PMID: 3892704 Document Number: 248867
Document emailed within 1 workday
Related Documents
Colpaert, F.C.; Janssen, P.A. 1982: Factors regulating drug cue sensitivity: the effects of dose ratio and absolute dose level in the case of fentanyl dose-dose discrimination Archives Internationales de Pharmacodynamie et de Therapie 258(2): 283-299Schneider, W.; Bussmann, W.D.; Stahl, B.; Wietschoreck, A.; Kaltenbach, M. 1985: The antianginal efficacy of isosorbide dinitrate: dose-response relation and long-term effects of high-dose treatment Zeitschrift für Kardiologie 74(Suppl 1): 55-63
Lissoni, P.; Brivio, F.; Brivio, O.; Fumagalli, L.; Gramazio, F.; Rossi, M.; Emanuelli, G.; Alderi, G.; Lavorato, F. 1995: Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients Journal of Biological Regulators and Homeostatic Agents 9(1): 31-33
Capizzi, R.L.; Powell, B.L. 1987: Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias Seminars in Oncology 14(2 Suppl 1: 40-50
Arlin, Z.A.; Feldman, E.J.; Finger, L.R.; Ahmed, T.; Mittelman, A.; Cook, P.; Puccio, C.; Baskind, P.; Arnold, P.; Razis, E.D. 1991: Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia Leukemia 5(8): 712-714
Hall, S.W.; Valdivieso, M.; Benjamin, R.S. 1977: Intermittent high single-dose ftorafur: phase i clinical trial with a pharmacologic-toxicity correlation Cancer Treatment Reports 61(8): 1495-1498
Garrido, G.; Bretó, M.; Pérez, F.; Berenguer, J. 1983: Comparative study of the effects of an average dose of chenodesoxycholic acid and a high dose of ursodesoxycholic acid (dosage equivalents: 15 mg/kg/day) on the composition of lipids and bile acids in the bile of patients with radiotransparent biliary lithiasis Revista Clinica Espanola 170(1-2): 31-36
Wheeler, R.H.; Ensminger, W.D.; Thrall, J.H.; Anderson, J.L. 1982: High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia Cancer Treatment Reports 66(3): 493-498
Lala, A.; Berger, J.S. 2011: Percutaneous coronary intervention for acute coronary syndromes: no difference in 30-day efficacy or safety of high- and low-dose aspirin; double-dose clopidogrel reduces 30-day risk of cardiovascular death, myocardial infarction or stroke compared with standard dose but increases risk of major bleeding Evidence-Based Medicine 16(3): 80-81
Tijssen, J.G. 1998: Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results Neurology 51(3 Suppl 3): S15-S16
Bhatia, A.; Tripathi, K.D.; Sharma, M. 2003: Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy Indian Journal of Medical Research 118: 33-41
Davis, J.C.; Fessler, B.J.; Tassiulas, I.O.; McInnes, I.B.; Yarboro, C.H.; Pillemer, S.; Wilder, R.; Fleisher, T.A.; Klippel, J.H.; Boumpas, D.T. 1998: High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis Journal of Rheumatology 25(9): 1694-1704
Hua, X.-m.; Ren, X.-w.; Liu, F.-l.; Liu, Y.; Zhang, C.-j.; Li, Z.-j.; Xu, L.; Liu, J.-y.; Liu, Y.-g. 2004: Comparision of high dose impulsion and low dose density chemotherapeutic regimens with paclitaxel plus cisplatin in advanced NSCLC Zhonghua Zhong Liu Za Zhi 26(10): 621-625
Poon, N.; Chaudakshetrin, P.; Sritongkul, N.; Tuntawiroon, M. 2016: Total Effective Dose Equivalent to Caregivers from Hospitalized Patients Treated with High Dose Radioiodine for Thyroid Carcinoma Journal of the Medical Association of Thailand 99(2): 225-230
Armenta, D.; Espallargas, C.; Paz, A.; Rodríguez Martorel, J.; Ladines, R.; Alvarez, C.; Román, J.; Andrés, P. 1996: Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan Sangre 41(6): 465-467
Rattanasupar, A.; Sengmanee, S. 2016: Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding Journal of the Medical Association of Thailand 99(9): 988-995
Fennelly, D.W.; Aghajanian, C.; Shapiro, F.; O'Flaherty, C.; O'Connor, K.; Curtin, J.P.; Crown, J.P.; Hoskins, W.J.; Spriggs, D.R. 1997: Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer Seminars in Oncology 24(1 Suppl 2: S2
Chevallier, B. 1990: Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S33-S36
Littlefield, N.A.; Farmer, J.H.; Gaylor, D.W.; Sheldon, W.G. 1980: Effects of dose and time in a long-term, low-dose carcinogenic study Journal of Environmental Pathology and Toxicology 3(Special Issue 3): 17-34
Gridley, D.S.; Pecaut, M.J.; Miller, G.M.; Moyers, M.F.; Nelson, G.A.; Nelson, G.A. 2001: Dose and dose rate effects of whole-body gamma-irradiation: II. Hematological variables and cytokines In Vivo 15(3): 209-216